Shigeki Bamba - Concepedia

Author

Shigeki Bamba

Shiga University of Medical Science ORCID

Also Known As

A Témé, Akira Andoh, Bamba, S., Johan Bakken, S Bamba, S. Bamba, SHIGEKI BAMBA, Shigeki Bamba

227

Publications

8.3K

Citations

H-Index

108

Concepts

All Affiliations

Shiga University of Medical Science Toho University Sapporo Kosei General Hospital Toho University Medical Center Sakura Hospital Shiga University of Medical Science Hospital

About

Shigeki Bamba is an author at Shiga University of Medical Science specializing in medicine, gastroenterology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	38	2.7K
2	Public Health	5	5	238
3	Health Sciences	4	4	178
4	Allergy	2	2	102
5	Biochemistry	1	1	101

Shigeki Bamba

105

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease Kenichiro Takahashi, Atsushi Nishida, Takehide Fujimoto, Digestion	2016	583
Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease Kyohei Nishino, Atsushi Nishida, Ryo Inoüe, Journal of Gastroenterology	2017	458
Decreased abundance of <i><scp>F</scp>aecalibacterium prausnitzii</i> in the gut microbiota of <scp>C</scp>rohn's disease Takehide Fujimoto, Hirotsugu Imaeda, Kenichiro Takahashi, Journal of Gastroenterology and Hepatology	2012	296
Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population Akira Andoh, Atsushi Nishida, Kenichiro Takahashi, Journal of Clinical Biochemistry and Nutrition	2016	248
Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis Ayako Kobori, Yuhki Yagi, Hirotsugu Imaeda, Journal of Gastroenterology InflammationChronic Inflammatory DiseasesAnti-inflammatoryMucosal ImmunologyInterleukin-33 Expression	2010	245
Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn’s disease using terminal restriction fragment length polymorphism analysis Akira Andoh, Hirotsugu Imaeda, Tomoki Aomatsu, Journal of Gastroenterology DysbiosisMucosal ImmunologyCrohn ’GastroenterologyPathology	2011	219
IL-17 stimulates inflammatory responses via NF-κB and MAP kinase pathways in human colonic myofibroblasts Kazunori Hata, Akira Andoh, Mitsue Shimada, American Journal of Physiology-Gastrointestinal and Liver Physiology Chronic Inflammatory DiseasesIl-6 SecretionImmunologyImmune RegulationImmune System	2002	212
Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis Makoto Naganuma, Shinya Sugimoto, Keiichi Mitsuyama, Gastroenterology InflammationFunctional Gastrointestinal DisorderGastroenterologyUlcerative ColitisMedicine	2017	188
Expression of IL-24, an Activator of the JAK1/STAT3/SOCS3 Cascade, Is Enhanced in Inflammatory Bowel Disease Akira Andoh, Makoto Shioya, Atsushi Nishida, The Journal of Immunology	2009	157
Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease Atsushi Nishida, Kentaro Hidaka, Toshihiro Kanda, Inflammatory Bowel Diseases	2016	127

Page 1